STEVEN BURTNER: Open Payments
NPI 1801205588 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 26 payments from 12 companies in 2025. Trend: 2023 $1,221 · 2024 $541 · 2025 $818
Food & beverage: $818
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $264 |
| AstraZeneca Pharmaceuticals LP | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $97 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Viatris Specialty LLC | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Genentech USA, Inc. | 1 | $30 |
Products named: CUVITRU, FASENRA, NUCALA, YUPELRI, ZEPBOUND, PURIFIED CORTROPHIN GEL, GLASSIA, ZERBAXA.
Industry payments across FL — which companies pay providers there.
